Northern-Most North American Flower Visitation Records of the Introduced Flower Fly, \u3ci\u3eSyritta Flaviventris\u3c/i\u3e (Diptera: Syrphidae) and Comparisons With Sympatric Species, \u3ci\u3eSyritta Pipiens\u3c/i\u3e

We report for the first time the syrphid fly, Syritta flaviventris (Macquart), collected in Lancaster County, Pennsylvania, as the northern-most record for this introduced Mediterranean species. In total, 3 male specimens and 1 female specimen were net collected on three flower species (Verbena hastata, Eryngium yuccifolium and Asclepias incarnata), at a single site of 11 monitored farm sites in southern Pennsylvania. Floral records for the similar introduced sibling species, Syritta pipiens (L.), are presented as well. Passive monitoring with colored pan traps used to monitor bee populations at these sites was not effective in collecting either species of Syritta. Our study suggests that increased active net sampling of Syritta species may provide more information about this genus\u27 distribution in the New World and support future research efforts examining Syritta biology and life history

The independent association of overweight and obesity with breathlessness in adults: a cross-sectional, population-based study

Obesity is an independent risk factor for chronic breathlessness and should be assessed in people with this symptom

Arenibacter amylolyticus sp. nov., an amylase- producing bacterium of the family Flavobacteriaceae isolated from marine water in India

A novel Gram- stain- negative, curved rod- shaped, 0.5?0.7 ?m wide and 3.0?10.0 ?m long, non- motile bacterium, designated strain AK53T, was isolated from a 5 m depth water sample collected from the Bay of Bengal, Visakhapatnam, India. Colonies on marine agar were circular, small, dark orange, shiny, smooth, translucent, flat, with an entire margin. The major fatty acids included iso-C15:0, iso-C15: 0 3OH, anteiso- C15:0, iso-C15: 1 G, iso- C17: 0 3OH and summed feature 3 (C16:1 ?7c and/or C16:1 ?6c and/or iso-C15:0- 2OH). Polar lipids included phosphatidylethanolamine and five unidentified lipids. The DNA G+C content of the strain AK53T was found to be 40.8 mol%. Phylogenetic analysis based on 16S rRNA gene sequences revealed that strain AK53T was closely related to Arenibacter latericius KMM 426T and Arenibacter certesii KMM3941T (pair- wise sequence similarity of 99.17 and 98.89 %, respectively), forming a distinct branch within the genus Arenibacter and clustering with A. latericius. Strain AK53T shared average nucleotide identity (ANIb, based on BLAST) of 78.07 and 77.44 % with A. latericius JCM 13508T and A. certesii JCM 13507T, respectively. Based on the observed phenotypic, chemotaxonomic characteristics and phylogenetic analysis, strain AK53T is described in this study as representing a novel species in the genus Arenibacter, for which the name Arenibacter amylolyticus sp. nov. is proposed. The type strain of Arenibacter amylolyticus is AK53T (=MTCC 12004T= JCM 19206T=KCTC 62553T)

Metabolomics characterization of Senna tora (L.) Roxb. using different approaches

The present study aimed to investigate the variety of elements, chemical compounds and their corresponding functional groups in the whole plant, leaves, and seeds of Senna tora. A preliminary phytochemical analysis has revealed the presence of secondary metabolites including alkaloids, flavonoids, tannins, terpenoids, cardiac active glycosides, phenolics, etc. Gas Chromatography and Mass Spectrophotometry (GC-MS) analysis of leaves and seeds of S. tora has depicted 31 and 27 compounds, respectively. Fourier Transform Infrared (FT-IR) Spectroscopy has further unveiled the presence of different functional groups such as amines, aromatic compounds, carboxyl groups, ketones etc. associated with different metabolites. Wavelength Dispersive X-ray Fluorescence (WD-XRF) has revealed the presence of more than 20 elements (macro and micro) including Ca, Mg, Fe, K, etc. This study has highlighted the detailed account of the chemical compounds and elements present in the plant species under investigation and substantiated its medicinal importance in the traditional health care system

Animal-Friendly Affinity Reagents: Replacing the Needless in the Haystack

The multibillion-dollar global antibody industry produces an indispensable resource but that is generated using millions of animals. Despite the irrefutable maturation and availability of animal-friendly affinity reagents (AFAs) employing na€ive B lymphocyte or synthetic recombinant technologies expressed by phage display, animal immunisation is still authorised for antibody production. Remarkably, replacement opportunities have been overlooked, despite the enormous potential reduction in animal use. Directive 2010/63/EU requires that animals are not used where alternatives exist. To ensure its implementation, we have engaged in discussions with the EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) and the Directorate General for Environment to carve out an EU-led replacement strategy. Measures must be imposed to avoid outsourcing, regulate commercial production, and ensure that antibody producers are fully supported